Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Atea Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −2 vs. Q4 2024
- Shares held
- 52.9M
- −3.10M (−5.5%) vs. Q4 2024
- Total value
- $158.3M
- −$29.4M (−15.7%) vs. Q4 2024
- New holders
- 9
- 36 more added
- Sold out
- 11
- 37 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 77 | $230 | 0.00% | −100−56.5% | Reduced |
| IFP Advisors, Inc | 0 | $51 | 0.00% | 0 | Unchanged |
| SBI Securities Co., Ltd. | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 82 | $0 | 0.00% | +15+22.4% | Added |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −3,341,653−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −77,581−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −67,304−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −47,166−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −13,966−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,817−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,426−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −1,584−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −479−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |